Context Therapeutics Inc. (CNTX) › Shareholders' EquityContext Therapeutics Inc. (CNTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$23.96M2020: -$16.92M2021: $48.27M2022: $34.76M2023: $11.87M2024: $95.27M2025: $60.47M$60.47M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$60.47M-36.5%2024$95.27M+702.5%2023$11.87M-65.8%2022$34.76M-28.0%2021$48.27M+385.3%2020-$16.92M+29.4%2019-$23.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share